Huapont Life Sciences Co Ltd (002004) — Cash Flow-to-Debt Ratio
Huapont Life Sciences Co Ltd (002004) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥635.17 Million could theoretically repay 0% of its total liabilities (CN¥13.15 Billion) in one year. See Huapont Life Sciences Co Ltd (002004) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Huapont Life Sciences Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Huapont Life Sciences Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see Huapont Life Sciences Co Ltd (002004) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Huapont Life Sciences Co Ltd. Check Huapont Life Sciences Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +49.6% |
| 2024 | 0.12x | CN¥1.63 Billion | CN¥13.98 Billion | ▲ +3.5% |
| 2023 | 0.11x | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -37.1% |
| 2022 | 0.18x | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +100.2% |
| 2021 | 0.09x | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -47.0% |
| 2020 | 0.17x | CN¥2.37 Billion | CN¥14.09 Billion | ▲ +8.3% |
| 2019 | 0.16x | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +12.4% |
| 2018 | 0.14x | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +269.3% |
| 2017 | 0.04x | CN¥591.40 Million | CN¥15.79 Billion | ▼ -1.1% |
| 2016 | 0.04x | CN¥511.90 Million | CN¥13.52 Billion | ▲ +2.8% |
| 2015 | 0.04x | CN¥342.45 Million | CN¥9.30 Billion | ▼ -36.7% |
| 2014 | 0.06x | CN¥455.96 Million | CN¥7.84 Billion | ▼ -39.5% |
| 2013 | 0.10x | CN¥349.51 Million | CN¥3.64 Billion | ▲ +10.6% |
| 2012 | 0.09x | CN¥257.75 Million | CN¥2.97 Billion | ▲ +3.1% |
| 2011 | 0.08x | CN¥135.23 Million | CN¥1.60 Billion | ▼ -65.9% |
| 2010 | 0.25x | CN¥79.84 Million | CN¥322.58 Million | ▼ -50.8% |
| 2009 | 0.50x | CN¥123.53 Million | CN¥245.68 Million | ▲ +43.8% |
| 2008 | 0.35x | CN¥113.76 Million | CN¥325.26 Million | ▲ +58.0% |
| 2007 | 0.22x | CN¥79.21 Million | CN¥357.78 Million | ▼ -18.9% |
| 2006 | 0.27x | CN¥66.10 Million | CN¥242.18 Million | ▼ -76.8% |
| 2005 | 1.18x | CN¥43.69 Million | CN¥37.17 Million | ▲ +32.2% |
| 2004 | 0.89x | CN¥70.60 Million | CN¥79.39 Million | ▲ +25.5% |
| 2003 | 0.71x | CN¥56.68 Million | CN¥79.99 Million | ▲ +101.6% |
| 2002 | 0.35x | CN¥36.88 Million | CN¥104.91 Million | — |